Loop-to-helix transition in the structure of multidrug regulator AcrR at the entrance of the drug-binding cavity

Journal of Structural Biology
Babu ManjasettyAndrzej Joachimiak

Abstract

Multidrug transcription regulator AcrR from Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 belongs to the tetracycline repressor family, one of the largest groups of bacterial transcription factors. The crystal structure of dimeric AcrR was determined and refined to 1.56Å resolution. The tertiary and quaternary structures of AcrR are similar to those of its homologs. The multidrug binding site was identified based on structural alignment with homologous proteins and has a di(hydroxyethyl)ether molecule bound. Residues from helices α4 and α7 shape the entry into this binding site. The structure of AcrR reveals that the extended helical conformation of helix α4 is stabilized by the hydrogen bond between Glu67 (helix α4) and Gln130 (helix α7). Based on the structural comparison with the closest homolog structure, the Escherichia coli AcrR, we propose that this hydrogen bond is responsible for control of the loop-to-helix transition within helix α4. This local conformational switch of helix α4 may be a key step in accessing the multidrug binding site and securing ligands at the binding site. Solution small-molecule binding studies suggest that AcrR binds ligands with their core chemical structure resembling the te...Continue Reading

References

Jul 1, 1995·Journal of Bacteriology·K E Hagman, W M Shafer
Jun 1, 1996·Current Opinion in Structural Biology·J F GibratS H Bryant
May 13, 1999·Bioinformatics·P GouetF Métoz
Oct 8, 1999·Emerging Infectious Diseases·P S MeadR V Tauxe
Dec 22, 1999·Emerging Infectious Diseases·C Hedberg
Feb 28, 2002·The EMBO Journal·Maria A SchumacherRichard G Brennan
May 4, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Morton N Swartz
Sep 5, 2002·Epidemiology and Infection·H HerikstadR V Tauxe
Mar 13, 2003·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·E J ThrelfallG Edwards
May 1, 1997·Acta Crystallographica. Section D, Biological Crystallography·G N MurshudovE J Dodson
Jun 10, 2005·Microbiology and Molecular Biology Reviews : MMBR·Juan L RamosRaquel Tobes
Dec 24, 2005·Journal of Synchrotron Radiation·Gerd RosenbaumAndrzej Joachimiak
Jul 21, 2006·Acta Crystallographica. Section D, Biological Crystallography·Wladek MinorMaksymilian Chruszcz
Feb 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·Robert Van der GeizeLindsay D Eltis
May 1, 2007·Journal of Molecular Biology·Yilmaz AlguelXiaodong Zhang
Jul 24, 2007·Biochemical and Biophysical Research Communications·Chih-Chia SuEdward W Yu
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Oct 24, 2007·Journal of Molecular Biology·Ming LiEdward W Yu
Apr 30, 2008·Antimicrobial Agents and Chemotherapy·Yousef M AbouzeedAxel Cloeckaert
Jul 9, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Ruoyu GuEdward W Yu
Feb 12, 2009·FEMS Microbiology Reviews·Jose Luis MartinezCarolina Alvarez-Ortega
Jun 23, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Remi M AjiboyeLee W Riley
Oct 13, 2009·Journal of Bacteriology·Marco BellinzoniPedro M Alzari
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Vincent B ChenDavid C Richardson
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Alexei Vagin, Alexei Teplyakov
Apr 20, 2010·Journal of Computer-aided Molecular Design·Daniel Seeliger, Bert L de Groot
Jul 20, 2010·Nature Structural & Molecular Biology·Darcie J MillerStephen W White
Jan 5, 2011·Emerging Infectious Diseases·Elaine ScallanPatricia M Griffin
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Garib N MurshudovAlexei A Vagin
Jun 27, 2013·Nature Communications·Suguru YamasakiKunihiko Nishino
Sep 6, 2013·Microbiology and Molecular Biology Reviews : MMBR·Leslie Cuthbertson, Justin R Nodwell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Protein Structures (ASM)

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.